Items Tagged ‘Rectal Cancer’

April 10, 2018

Managing Side Effects From EGFR Inhibitors

By

CancerConnect News: Epidermal Growth Factor Receptor (EGFR) inhibitor drugs are a type of precision cancer medicine commonly used to treat lung, colon, head and neck and other cancers that over express the EGFR.  There are several EGFR inhibitor drugs and these cause similar side effects. The EGFR pathway is a normal biologic pathway found in […]

View full entry

Tags: cetuximab, Colon Cancer, diarrhea, EGFR inhibitors, erbitux, erlotinib, gefitinib, Head and Neck Cancer, iressa, Lung Cancer, News, Panutumamab


October 16, 2017

Targeting both BRAF and EGFR doubles progression-free survival in metastatic colorectal cancer

By

Recent successes in genetically targeted precision cancer medicines are improving outcomes in a number of cancers.  Ensuring patients undergo genomic sequencing to determine if they have treatable targets is increasingly important to ensure patients receive the most appropriate personalized care. Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalities in […]

View full entry

Tags: BRAF, Colon Cancer, erbitux, News, Precision Cancer Medicine, Rectal Cancer, V600E, vemurafenib, zelboraf


September 18, 2017

NSAIDs Decrease Risk of Colorectal Cancer

By

Nonsteroidal anti-inflammatory drugs (NSAIDS) are medicines that are used for the treatment of a wide range of musculoskeletal illnesses including spinal disorders, osteoarthritis and inflammatory conditions like rheumatoid arthritis. NSAIDs effectively relieve pain, inflammation, and fever.  A number of treatment guidelines for osteoarthritis, rheumatoid arthritis, and chronic low back pain recommend the use of NSAIDs […]

View full entry

Tags: Colon Cancer, News, Rectal Cancer


April 29, 2011

Delay in Chemotherapy Increases Risk of Death in Colorectal Cancer

By

When chemotherapy for colorectal cancer is delayed by more than four weeks following surgery, patients face an increased risk of death. These findings were recently reported at the American Society of Clinical Oncology’s annual Gastrointestinal Cancers Symposium. Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Stage III colorectal cancer […]

View full entry

Tags: Adjuvant (I-III, A-C) Colon Cancer, Colon Cancer, Rectal Cancer, Stages I-III Rectal Cancer